Search clinical trials for: epirubicin combined with cyclophosphamide and sequential docetaxel

Total 1621 results

Peng Liu

Not yet recruiting

The Efficacy and Safety of Nanoparticle Albumin-bound (NAB)-Paclitaxel Plus Cisolation Versus CEP (Cisplatin, Epirubicin,Cyclophosphamide) in Induction Therapy for Thymoma: a Study for a Single-center Prospective Phase II Randomized Controlled Train.

Histological or Cytological Confirmed Stage Ⅲ and Ⅳa Thymoma

China
IRCCS Azienda Ospedaliera Universitaria San Martino...

Completed

Adjuvant FEC Versus EP in Breast Cancer (MIG5) (MIG5)

Breast Cancer | Chemotherapy, Adjuvant

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Completed

A Phase II Study of Dose Density Regimen With Fluorouracil, Epirubicin and Cyclophosphamide at Days 1, 4 Every 14 Days With Filgrastim Support Followed by Weekly Paclitaxel in Women With Primary Breast Cancer.

Women With Primary Breast Cancer

Italy
IRCCS Azienda Ospedaliera Universitaria San Martino...

Unknown

Combination Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer

Breast Cancer

Italy
Jian Chen

Recruiting

Clinical Study of Postoperative Carbon Ion Radiotherapy for Thymus Tumor With Residual Tumor

Thymic Epithelial Tumor | Radiotherapy Side Effect | Carbon Ion Radiotheray | Heavy Ion Radiotherapy

China
iSTAR Medical

Enrolling by invitation

MINIject Implantation Combined With Cataract Surgery in Patients With POAG and Cataract (STAR-VI)

Cataract | Primary Open-angle Glaucoma

Spain, Panama, United Kingdom
General Hospital Murska Sobota
University of Primorska; University of Ljubljana

Unknown

Resistance Training in Cardiovascular Disease Patients (RT in CVD)

Coronary Artery Disease | Heart Failure With Reduced Ejection Fraction

Slovenia
Tianjin Medical University Cancer Institute and...

Recruiting

Immune Checkpoint Inhibitor PD-1 Antibody Combined With Chemotherapy in the Perioperative Treatment of Locally Advanced Resectable Gastric or Gastroesophageal Junction Adenocarcinoma

Locally Advanced Gastric Adenocarcinoma

China
Simcere Pharmaceutical Co., Ltd
Daping Hospital and the Research Institute of Surgery of the Third Military...

Unknown

Study of Concurrent Chemo-radiotherapy Combined With Recombinant Human Endostatin for Local Advanced Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer

China
Shanghai Zhongshan Hospital

Recruiting

Zimberelimab Combined With Concurrent Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer

Locally Advanced Cervical Cancer

China
Guoxin Li

Not yet recruiting

Disitamab Vedotin Combined With PD-1 and Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer（RC48-C018）

Gastric Cancer
Yonsei University

Completed

An Open-label, Multi-center Phase Ⅳ Trial to Evaluate the Efficacy and Safety of Sequential Neoadjuvant Chemotherapy With Docetaxel(Monotaxel®) After Doxorubicin Plus Cyclophosphamide Combination Chemotherapy in Locally Advanced Breast Cancer

Locally Advanced Breast Cancer

Korea, Republic of
Providence Health & Services
Sanofi; Providence Cancer Center, Earle A. Chiles Research Institute

Terminated

Trial of Neoadjuvant Docetaxel and Cisplatin for Resectable Non-Small Cell Lung Cancer

Non-small-Cell Lung Carcinoma

United States
Second Affiliated Hospital, School of Medicine,...

Recruiting

AC vs TC in Patients With HR-positive, HER2-negative Early Breast Cancer

Breast Cancer | Chemotherapeutic Toxicity

China
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI); Pharmacia; Amgen

Completed

Neoadjuvant or Adjuvant Epirubicin, Cyclophosphamide, and Paclitaxel in Treating Women With Stage I, Stage II, or Stage III Breast Cancer

Breast Cancer

United States
Cancer Institute and Hospital, Chinese Academy...

Unknown

The Trial Comparing Dose-dense AC-T With PC as Adjuvant Therapy for TNBC

Breast Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Study of Anlotinib Plus Chemotherapy as the First-line Treatment in Patients With Advanced NSCLC

Adenocarcinoma | NSCLC | Squamous Cell Carcinoma
Shanghai Henlius Biotech

Not yet recruiting

to Evaluate Efficacy and Safety of HLX10 in Combination With Chemotherapy Versus Placebo in Combination With Chemotherapy as Neoadjuvant Therapy and HLX10 Versus Placebo as Adjuvant Therapy in Patients With Triple Negative Breast Cancer (TNBC)

Triple Negative Breast Cancer
Cancer Institute and Hospital, Chinese Academy...

Unknown

Toripalimab Combine With Rituximab for Treatment of Relapsed Refractory CD20 Positive Diffuse Large B-cell Lymphoma

Diffuse Large B-cell Lymphoma | Rituximab | Toripalimab

China
Zhejiang Cancer Hospital

Recruiting

Clinical Study on the First-line Treatment of Advanced Biliary System Tumors With Tripley Monoclonal Antibody Combined With GEMOX Regimen

Advanced Biliary Tract Tumors

China
Medical University of Gdansk

Not yet recruiting

Effect of CoQ10 on the Endocrine Function of Skeletal Muscle

Exercise Training | Ischemic Preconditioning | Coenzyme Q Deficiency

Poland
Fudan University

Unknown

Cisplatin Combined With S-1 or Paclitaxel as First-line Treatment for Metastatic Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma

China
UNICANCER

Terminated

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors

Testicular Germ Cell Tumor | Ovarian Cancer | Extragonadal Germ Cell Tumor | Childhood Germ Cell Tumor

France
National University Hospital, Singapore

Recruiting

Cisplatin Combined With Oral TS-1 in Patients With Advanced Solid Tumors With Different Degrees of Liver Dysfunction

Cancer | Liver Dysfunction

Singapore
First Affiliated Hospital, Sun Yat-Sen University

Not yet recruiting

TACE Plus HAIC Combined With Regorafenib for Liver Metastasis of Colorectal Cancer Refractory to Standard Treatment Regimens

Liver Metastasis Colon Cancer

China
SCRI Development Innovations, LLC
Aventis Pharmaceuticals; Pharmacia and Upjohn

Terminated

Epirubicin and Docetaxel in the Treatment of Patients With Metastatic Breast Cancer

Breast Cancer
National Yang Ming University

Completed

Lumbopelvic Movement Control: Effect of Injury History, and the Role of Cortical Control and Its Practical Application 2

Biomechanical Phenomena

Taiwan
Association Européenne de Recherche en Oncologie
Bristol-Myers Squibb

Unknown

6 FEC 100 Vs 4 FEC 100 Followed by 4 Taxol in N+ Breast Cancer

Breast Cancer
Masonic Cancer Center, University of Minnesota

Terminated

Vegetable Intake Effect on Heterocyclic Amine Metabolism

Colon Cancer

United States
West German Study Group

Active, not recruiting

ADAPT - Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early Breast Cancer (ADAPT)

Breast Cancer

Germany
Prestige Biopharma Limited

Completed

A Phase III Trial to Compare the Efficacy, Safety and Pharmacokinetics of HD201 to Herceptin® in HER2+ Early Breast Cancer Patients (TROIKA)

HER2 Positive Breast Cancer

Spain, Malaysia, Estonia, Hungary, Thailand, Belarus, Bulgaria, France, Georgia, Italy, Poland, Russian Federation, Ukraine
Shanghai Jiao Tong University School of Medicine

Completed

Study of Danggui Buxue Decoction in Preventing Neutropenia (DIPE)

Febrile Neutropenia | Grade 3/4 Neutropenia

China
Yonsei University

Withdrawn

An Open-label Phase Ib/II Study of BAY 1000394 (Roniciclib) in Combination With Docetaxel in Second- or Third-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

NSCLC (Non-Small Cell Lung Cancer)
Second Affiliated Hospital of Wenzhou Medical University

Not yet recruiting

MRD-positive Colorectal Cancer Patients Combined With Personalized Immune Regulation Diagnosis

Colorectal Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

A Prospective, Single-arm Clinical Study of Pabrolizumab in Combination With Cisplatin + 5-FU for the Neoadjuvant Treatment of Unresectable, Advanced Squamous Carcinoma of the Temporal Bone Single-arm Clinical Study

Temporal Bone Squamous Cell Carcinoma

China
Azienda Ospedaliero-Universitaria di Modena

Unknown

Combination Chemotherapy and Trastuzumab in Treating Women With Stage I, Stage II, or Stage III HER2-Positive Breast Cancer

Breast Cancer

Italy
RenJi Hospital

Recruiting

Combination of RC48 and Tislelizumab for Renal Preservation in High-risk UTUC Patients

Upper Urinary Tract Urothelial Carcinoma | Kidney Preservation | HER-2 ADC | PD-1antibody

China
Institut Mutualiste Montsouris
University of Turin, Italy

Recruiting

EvaluatioN of HIFU Hemiablation and Short Term AndrogeN Deprivation Therapy Combination to Enhance Prostate Cancer Control. (ENHANCE)

Prostate Cancer | Androgen Deprivation Therapy

France
University of Roma La Sapienza

Completed

Progressive Modular Rebalancing (RMP) System Rehabilitation Combined With Sensory Cues for Rehabilitation of Patients With PD

Parkinson Disease | Movement Disorders

Italy
US Oncology Research
Sanofi

Completed

Adj TC + Herceptin Early Stage Breast Cancer

Breast Cancer

United States
Terezinha de Jesus Esteves Barata

Completed

Combined Bleaching Technique: Efficacy and Tooth Sensitivity

Tooth Bleaching | Tooth Sensitivity
Medical University of Silesia
Ministry of Scientific Research and Information Technology, Poland

Completed

Effects of Hypolipemic Treatment on Adipokines

Hyperlipidemia | Impaired Fasting Glycemia

Poland
Institute of Cancer Research, United Kingdom

Unknown

Combination Chemotherapy in Treating Women With Resected Breast Cancer

Breast Cancer

United Kingdom, Belgium
EVIVE Biotechnology
Fudan University

Completed

Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy

Breast Cancer | Neutropenia
Henan Cancer Hospital

Completed

Comparison of TP and TAC Regimens in Neoadjuvant Treatment of TNBC

Triple Negative Breast Cancer

China
Chinese PLA General Hospital

Completed

Low Dose Ruxolitinib in Combination With Methylprednisolone

Stem Cell Transplant Complications | aGVHD

China
Nanjing First Hospital, Nanjing Medical University

Recruiting

Fucoidan Assisted Eradication of Helicobacter Pylori

Helicobacter Pylori Infection | Intestinal Bacteria Flora Disturbance

China
Vejle Hospital

Completed

Tocotrienol in Combination With Neoadjuvant Chemotherapy for Women With Breast Cancer (NeoToc)

Breast Cancer

Denmark
NSABP Foundation Inc
AstraZeneca

Completed

Therapy With Docetaxel and ZD1839 for Patients Who Have Advanced Breast Cancer

Breast Neoplasms

United States
Xuekui Liu

Not yet recruiting

A Prospective, Single-arm Phase II Clinical Trial of Tislelizumab Combined With Platinum Doublet Neoadjuvant Therapy to Improve Mandibular Preservation in Resectable Locally Advanced Oral Squamous Cell Carcinoma. (B2023-153)

Oral Squamous Cell Carcinoma

3

Subscribe